| [1] |
Li X, Zhang Q, Nasser MI, et al. Oxygen homeostasis and cardiovascular disease: A role for HIF[J]. Biomed Pharmacother, 2020, 128: 110338. doi:10.1016/j.biopha.2020.110338
|
| [2] |
Xie SY, Xing Y, Shi WK, et al. Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia-reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination[J]. Acta Pharm Sin B, 2022, 12(11): 4138-53. doi:10.1016/j.apsb.2022.07.022
|
| [3] |
Bacmeister L, Schwarzl M, Warnke S, et al. Inflammation and fibrosis in murine models of heart failure[J]. Basic Res Cardiol, 2019, 114(3): 19. doi:10.1007/s00395-019-0722-5
|
| [4] |
Wang JH, Chen X, Huang W. microRNA-369 attenuates hypoxia-induced cardiomyocyte apoptosis and inflammation via targeting TRPV3[J]. Braz J Med Biol Res, 2021, 54(3): e10550. doi:10.1590/1414-431x202010550
|
| [5] |
Baehr A, Umansky KB, Bassat E, et al. Agrin promotes coordinated therapeutic processes leading to improved cardiac repair in pigs[J]. Circulation, 2020, 142(9): 868-81. doi:10.1161/circulationaha.119.045116
|
| [6] |
Feng JJ, Zhan JC, Ma SS. LRG1 promotes hypoxia-induced cardiomyocyte apoptosis and autophagy by regulating hypoxia-inducible factor-1α[J]. Bioengineered, 2021, 12(1): 8897-907. doi:10.1080/21655979.2021.1988368
|
| [7] |
Han CS, Yang JJ, Sun JC, et al. Extracellular vesicles in cardiovascular disease: Biological functions and therapeutic implications[J]. Pharmacol Ther, 2022, 233: 108025. doi:10.1016/j.pharmthera.2021.108025
|
| [8] |
Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367(6478): eaau6977. doi:10.1126/science.aau6977
|
| [9] |
Pan YH, Wu WP, Jiang XX, et al. Mesenchymal stem cell-derived exosomes in cardiovascular and cerebrovascular diseases: From mechanisms to therapy[J]. Biomed Pharmacother, 2023, 163: 114817. doi:10.1016/j.biopha.2023.114817
|
| [10] |
Zhang ZB, Zou YM, Song CY, et al. Advances in the study of exosomes in cardiovascular diseases[J]. J Adv Res, 2024, 66: 133-53. doi:10.1016/j.jare.2023.12.014
|
| [11] |
Tian Z, Ning H, Wang XY, et al. Endothelial autophagy promotes atheroprotective communication between endothelial and smooth muscle cells via exosome-mediated delivery of miR-204-5p[J]. Arterioscler Thromb Vasc Biol, 2024, 44(8): 1813-32. doi:10.1161/atvbaha.123.319993
|
| [12] |
Otani K, Yokoya M, Kodama T, et al. Plasma exosomes regulate systemic blood pressure in rats[J]. Biochem Biophys Res Commun, 2018, 503(2): 776-83. doi:10.1016/j.bbrc.2018.06.075
|
| [13] |
Wang C, Li ZL, Liu YN, et al. Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets[J]. Theranostics, 2021, 11(8): 3996-4010. doi:10.7150/thno.56035
|
| [14] |
Wang Y, Zhao RZ, Shen CY, et al. Exosomal CircHIPK3 released from hypoxia-induced cardiomyocytes regulates cardiac angiogenesis after myocardial infarction[J]. Oxid Med Cell Longev, 2020, 2020: 8418407. doi:10.1155/2020/8418407
|
| [15] |
Liu SJ, Chen J, Shi J, et al. M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment[J]. Basic Res Cardiol, 2020, 115(2): 22. doi:10.1007/s00395-020-0781-7
|
| [16] |
Zhao YC, Xiong WD, Li CF, et al. Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets[J]. Signal Transduct Target Ther, 2023, 8(1): 431. doi:10.1038/s41392-023-01652-9
|
| [17] |
Ding J, Wang BY, Yang YF, et al. Ciprofol ameliorates myocardial ischemia/reperfusion injury by inhibiting ferroptosis through upregulating HIF-1α[J]. Drug Des Devel Ther, 2024, 18: 6115-32. doi:10.2147/dddt.s480514
|
| [18] |
Maimaitiaili N, Zeng YX, Ju PN, et al. NLRC3 deficiency promotes hypoxia-induced pulmonary hypertension development via IKK/NF-κB p65/HIF-1α pathway[J]. Exp Cell Res, 2023, 431(2): 113755. doi:10.1016/j.yexcr.2023.113755
|
| [19] |
Sun JC, Shen H, Shao LB, et al. HIF-1α overexpression in mesenchymal stem cell-derived exosomes mediates cardiopro-tection in myocardial infarction by enhanced angiogenesis[J]. Stem Cell Res Ther, 2020, 11(1): 373. doi:10.1186/s13287-020-01881-7
|
| [20] |
Wen ZZ, Mai Z, Zhu XL, et al. Mesenchymal stem cell-derived exosomes ameliorate cardiomyocyte apoptosis in hypoxic conditions through microRNA144 by targeting the PTEN/AKT pathway[J]. Stem Cell Res Ther, 2020, 11(1): 36. doi:10.1186/s13287-020-1563-8
|
| [21] |
Fang TT, Ma CC, Yang BY, et al. Roxadustat improves diabetic myocardial injury by upregulating HIF-1α/UCP2 against oxidative stress[J]. Cardiovasc Diabetol, 2025, 24(1): 67. doi:10.1186/s12933-025-02601-2
|
| [22] |
Ikeda M, Ide T, Tadokoro T, et al. Excessive hypoxia-inducible factor-1α expression induces cardiac rupture via p53-dependent apoptosis after myocardial infarction[J]. J Am Heart Assoc, 2021, 10(17): e020895. doi:10.1161/jaha.121.020895
|
| [23] |
Yang Z, Huang YJ, Zhu L, et al. SIRT6 promotes angiogenesis and hemorrhage of carotid plaque via regulating HIF-1α and reactive oxygen species[J]. Cell Death Dis, 2021, 12: 77. doi:10.1038/s41419-020-03372-2
|
| [24] |
Janbandhu V, Tallapragada V, Patrick R, et al. Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction[J]. Cell Stem Cell, 2022, 29(2): 281-97. e12. doi:10.1016/j.stem.2021.10.009
|
| [25] |
Bao QK, Zhang BY, Zhou L, et al. CNP ameliorates macrophage inflammatory response and atherosclerosis[J]. Circ Res, 2024, 134(8): e72-91. doi:10.1161/circresaha.123.324086
|
| [26] |
Lei L, Mason S, Liu DG, et al. Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein. Mol[J]. Cell Biol, 2008, 28: 3790-803. doi:10.1128/mcb.01580-07
|
| [27] |
Lian G, Li XP, Zhang LQ, et al. Macrophage metabolic reprogramming aggravates aortic dissection through the HIF1α-ADAM17 pathway[J]. eBioMedicine, 2019, 49: 291-304. doi:10.1016/j.ebiom.2019.09.041
|
| [28] |
Wang J, Wang XJ, Zhang Y, et al. TXNIP knockout improves cardiac function after myocardial infarction by promoting angiogenesis and reducing cardiomyocyte apoptosis[J]. Cardiovasc Diagn Ther, 2022, 12(3): 289-304. doi:10.21037/cdt-21-732
|
| [29] |
Sui XZ, Wei HC, Wang DC. Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction[J]. J Cell Mol Med, 2015, 19(8): 1773-82. doi:10.1111/jcmm.12551
|
| [30] |
Viswanadha VP, Dhivya V, Beeraka NM, et al. The protective effect of piperine against isoproterenol-induced inflammation in experimental models of myocardial toxicity[J]. Eur J Pharmacol, 2020, 885: 173524. doi:10.1016/j.ejphar.2020.173524
|
| [31] |
Refaie MMM, El-Hussieny M, Abdel-Hakeem EA, et al. Phosphodiesterase inhibitor, Vinpocetine, guards against doxorubicin induced cardiotoxicity via modulation of HIF/VEGF and cGMP/cAMP/SIRT signaling pathways[J]. Hum Exp Toxicol, 2022, 41: 09603271221136209. doi:10.1177/09603271221136209
|